A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer

Oncology

Volumn 70, Issue 1, 2006, Pages 19-24

  Miglietta, L ^a   Franzone, P ^a   Centurioni, M G ^a   Boni, L ^a   Tacchini, L ^a   Cosso, M ^a   Boccardo, F ^a,b   Ferrarini, M ^a,b   Bruzzone, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Advanced cervical cancer; Cisplatin; Radiotherapy; Taxol

Indexed keywords

ANTIHISTAMINIC AGENT; CISPLATIN; CORTICOSTEROID; ERYTHROPOIETIN; PACLITAXEL; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; ASTHENIA; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DIARRHEA; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ENTERITIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; HYPOMAGNESEMIA; KIDNEY TUBULE DISORDER; LEUKOPENIA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; RADIATION INJURY; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

EID: 33644898109     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091182     Document Type: Article

References (15)

1. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, Clarke-Pearson DL, Liao SY: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes : a Gynaecologic Oncology Group And Southwest Oncology Group study. J Clin Oncol 1999;17:1339-1348.
2. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153.
3. Keys HM, Bundy B, Stehman FB, Muderspach L, Chafe WE, Suggs CL, Walzer JL, Gersell D: Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161.
4. Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W, Alberts DS: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-1613.
5. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143.
6. Thigpen T, Vance R, Khansur T, Malamud F: The role of paclitaxel in the management of patients with carcinoma of the cervix. Semin Oncol 1987;24(1 suppl 2):S2-41-S2-46.
7. Rose PG, Blessing JA, Gershenson DM, McGehee R: Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix. J Clin Oncol 1999;17:2676-2680.
8. Pignata S, Frezza P, Tramontana S, Perrone F, Tamburo R, Casella G, Ferrari E, Iodica F, De Vivo R, Ricchi P, Tramontana F, Silvestro G: Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri. Ann Oncol 2000;1184:455-459.
9. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981;47:207-214.
10. Simon R: Optimal two-stage design for phase II clinical trials. Control Clin Trials 1989;10:1-10.
11. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-786.
12. Ijaz T, Eifel PJ, Burke T, Oswald MJ: Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1998;70:241-246.
13. Fyles AW, Pintilie M, Kirkbride P, et al: Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 1995;35:107-117.
14. Sood BM, Gorla GR, Garg M, Anderson PS, Fields AL, Runowicz CD, Goldberg GL, Vikram B: Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix. Cancer 2003;97:1781-1788.
15. Bae SN, Namkoong SE, Jung JK, et al: Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1997;64:418-424.